Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes

To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012. Pregnant women we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ENDOCRINE JOURNAL 2023, Vol.70(6), pp.611-618
Hauptverfasser: Chen, Liangmiao, Ye, Enling, Sun, Mengli, Lin, Hai, Yu, Lechu, Lin, Zhenzhen, Peng, Mengmeng, Lin, Dini, Lu, Xuemian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 618
container_issue 6
container_start_page 611
container_title ENDOCRINE JOURNAL
container_volume 70
creator Chen, Liangmiao
Ye, Enling
Sun, Mengli
Lin, Hai
Yu, Lechu
Lin, Zhenzhen
Peng, Mengmeng
Lin, Dini
Lu, Xuemian
description To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012. Pregnant women were assigned to two groups, a hypothyroxinemia group (with maternal isolated hypothyroxinemia in the third trimester and normal thyroid function in the first and second trimesters) and a control group (with normal serum thyroid functions). The pregnancy outcomes, including preterm birth, fetal distress, birth weight, premature rupture of membranes, and Apgar score at one minute after the birth, were recorded and compared between the two groups. A total of 3,945 pregnant women (median age 26 year old) were included in the study, with 195 women in the hypothyroxinemia group and 3,750 women in the control group. Compared with the women in the control group, women in the hypothyroxinemia group had higher incidences of premature rupture of membranes and low Apgar score at one minute after the birth. The multivariate logistic regression analysis showed that the low third trimester serum thyroxine level was the independent risk factor for the premature rupture of membranes and low Apgar score. There were no statistically significant differences in preterm birth, macrosomia, and intrauterine fetal distress between two groups. Third trimester maternal isolated hypothyroxinemia was associated with adverse pregnancy outcomes. The maternal serum thyroxine level should be monitored during late pregnancy and necessary management should be applied to improve the pregnancy outcomes.
doi_str_mv 10.1507/endocrj.EJ22-0528
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799172415</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2799172415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-ea9fe2eda37604b82d1800907587b9dee0352c62068a8ebe531dc30c585f5ec23</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxSMEokvhA3BBlrhwSRn_i51jVZUCqsQFzpbjzHa9SuKt7QD77XHYJSAuM5b885vneVX1msIVlaDe49QHF_dXt58Zq0Ey_aTaUC50LaSAp9UGWqpr3cr2onqR0h6Acyn48-qCK-AMGrmp8Dql4LzNPkykw_wDcSJ552NPcvQjpoyRjLbUyQ7EpzCUc092x0PIu2MMP_2Eo7fETj2x_XeMCckh4sNkJ3ckYc4uFJGX1bOtHRK-OvfL6tuH2683H-v7L3efbq7va9cIlWu07RYZ9parBkSnWU81QAtKatW1PSJwyVxTnGursUPJae84OKnlVqJj_LJ6d9I9xPA4F_Nm9MnhMNgJw5wMU21LFRNUFvTtf-g-zMsnC6UliEZRaAtFT5SLIaWIW3MoW7HxaCiYJQNzzsAsGZglg_LmzVl57kbs1xd_ll6AuxNQbr2zQ5iGssW_891j81vVMGDcACiApjRtoKF0KVowzsS_SvuU7QOuo2zM3g24mlNgmqWsJlfC7WwsGP8F98i14Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2850467109</pqid></control><display><type>article</type><title>Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes</title><source>J-STAGE Free</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Chen, Liangmiao ; Ye, Enling ; Sun, Mengli ; Lin, Hai ; Yu, Lechu ; Lin, Zhenzhen ; Peng, Mengmeng ; Lin, Dini ; Lu, Xuemian</creator><creatorcontrib>Chen, Liangmiao ; Ye, Enling ; Sun, Mengli ; Lin, Hai ; Yu, Lechu ; Lin, Zhenzhen ; Peng, Mengmeng ; Lin, Dini ; Lu, Xuemian ; Shandong Provincial Hospital ; Third Affiliated Hospital of Wenzhou Medical University ; Department of Endocrinology ; Shandong University</creatorcontrib><description>To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012. Pregnant women were assigned to two groups, a hypothyroxinemia group (with maternal isolated hypothyroxinemia in the third trimester and normal thyroid function in the first and second trimesters) and a control group (with normal serum thyroid functions). The pregnancy outcomes, including preterm birth, fetal distress, birth weight, premature rupture of membranes, and Apgar score at one minute after the birth, were recorded and compared between the two groups. A total of 3,945 pregnant women (median age 26 year old) were included in the study, with 195 women in the hypothyroxinemia group and 3,750 women in the control group. Compared with the women in the control group, women in the hypothyroxinemia group had higher incidences of premature rupture of membranes and low Apgar score at one minute after the birth. The multivariate logistic regression analysis showed that the low third trimester serum thyroxine level was the independent risk factor for the premature rupture of membranes and low Apgar score. There were no statistically significant differences in preterm birth, macrosomia, and intrauterine fetal distress between two groups. Third trimester maternal isolated hypothyroxinemia was associated with adverse pregnancy outcomes. The maternal serum thyroxine level should be monitored during late pregnancy and necessary management should be applied to improve the pregnancy outcomes.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.EJ22-0528</identifier><identifier>PMID: 37032065</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Adult ; Apgar score ; Birth weight ; Female ; Fetal Distress ; Fetuses ; Humans ; Infant, Newborn ; Pregnancy ; Pregnancy Complications - epidemiology ; Pregnancy Outcome ; Pregnancy Trimester, Third ; Premature Birth ; Premature rupture of membranes ; Retrospective Studies ; Risk factors ; Rupture ; Statistical analysis ; Third trimester ; Thyroid ; Thyroid function ; Thyroid gland ; Thyroxine</subject><ispartof>Endocrine Journal, 2023, Vol.70(6), pp.611-618</ispartof><rights>The Japan Endocrine Society</rights><rights>Copyright Japan Science and Technology Agency 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-ea9fe2eda37604b82d1800907587b9dee0352c62068a8ebe531dc30c585f5ec23</citedby><cites>FETCH-LOGICAL-c647t-ea9fe2eda37604b82d1800907587b9dee0352c62068a8ebe531dc30c585f5ec23</cites><orcidid>0000-0003-0882-4816 ; 0000-0002-0560-4028 ; 0000-0002-6687-5825 ; 0000-0003-4528-6981 ; 0000-0001-8282-3323 ; 0000-0002-2927-1731 ; 0000-0002-9702-6770 ; 0000-0002-5568-1531 ; 0000-0002-6716-3344</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,1881,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37032065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Liangmiao</creatorcontrib><creatorcontrib>Ye, Enling</creatorcontrib><creatorcontrib>Sun, Mengli</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Yu, Lechu</creatorcontrib><creatorcontrib>Lin, Zhenzhen</creatorcontrib><creatorcontrib>Peng, Mengmeng</creatorcontrib><creatorcontrib>Lin, Dini</creatorcontrib><creatorcontrib>Lu, Xuemian</creatorcontrib><creatorcontrib>Shandong Provincial Hospital</creatorcontrib><creatorcontrib>Third Affiliated Hospital of Wenzhou Medical University</creatorcontrib><creatorcontrib>Department of Endocrinology</creatorcontrib><creatorcontrib>Shandong University</creatorcontrib><title>Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012. Pregnant women were assigned to two groups, a hypothyroxinemia group (with maternal isolated hypothyroxinemia in the third trimester and normal thyroid function in the first and second trimesters) and a control group (with normal serum thyroid functions). The pregnancy outcomes, including preterm birth, fetal distress, birth weight, premature rupture of membranes, and Apgar score at one minute after the birth, were recorded and compared between the two groups. A total of 3,945 pregnant women (median age 26 year old) were included in the study, with 195 women in the hypothyroxinemia group and 3,750 women in the control group. Compared with the women in the control group, women in the hypothyroxinemia group had higher incidences of premature rupture of membranes and low Apgar score at one minute after the birth. The multivariate logistic regression analysis showed that the low third trimester serum thyroxine level was the independent risk factor for the premature rupture of membranes and low Apgar score. There were no statistically significant differences in preterm birth, macrosomia, and intrauterine fetal distress between two groups. Third trimester maternal isolated hypothyroxinemia was associated with adverse pregnancy outcomes. The maternal serum thyroxine level should be monitored during late pregnancy and necessary management should be applied to improve the pregnancy outcomes.</description><subject>Adult</subject><subject>Apgar score</subject><subject>Birth weight</subject><subject>Female</subject><subject>Fetal Distress</subject><subject>Fetuses</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - epidemiology</subject><subject>Pregnancy Outcome</subject><subject>Pregnancy Trimester, Third</subject><subject>Premature Birth</subject><subject>Premature rupture of membranes</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Rupture</subject><subject>Statistical analysis</subject><subject>Third trimester</subject><subject>Thyroid</subject><subject>Thyroid function</subject><subject>Thyroid gland</subject><subject>Thyroxine</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9v1DAQxSMEokvhA3BBlrhwSRn_i51jVZUCqsQFzpbjzHa9SuKt7QD77XHYJSAuM5b885vneVX1msIVlaDe49QHF_dXt58Zq0Ey_aTaUC50LaSAp9UGWqpr3cr2onqR0h6Acyn48-qCK-AMGrmp8Dql4LzNPkykw_wDcSJ552NPcvQjpoyRjLbUyQ7EpzCUc092x0PIu2MMP_2Eo7fETj2x_XeMCckh4sNkJ3ckYc4uFJGX1bOtHRK-OvfL6tuH2683H-v7L3efbq7va9cIlWu07RYZ9parBkSnWU81QAtKatW1PSJwyVxTnGursUPJae84OKnlVqJj_LJ6d9I9xPA4F_Nm9MnhMNgJw5wMU21LFRNUFvTtf-g-zMsnC6UliEZRaAtFT5SLIaWIW3MoW7HxaCiYJQNzzsAsGZglg_LmzVl57kbs1xd_ll6AuxNQbr2zQ5iGssW_891j81vVMGDcACiApjRtoKF0KVowzsS_SvuU7QOuo2zM3g24mlNgmqWsJlfC7WwsGP8F98i14Q</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Chen, Liangmiao</creator><creator>Ye, Enling</creator><creator>Sun, Mengli</creator><creator>Lin, Hai</creator><creator>Yu, Lechu</creator><creator>Lin, Zhenzhen</creator><creator>Peng, Mengmeng</creator><creator>Lin, Dini</creator><creator>Lu, Xuemian</creator><general>The Japan Endocrine Society</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0882-4816</orcidid><orcidid>https://orcid.org/0000-0002-0560-4028</orcidid><orcidid>https://orcid.org/0000-0002-6687-5825</orcidid><orcidid>https://orcid.org/0000-0003-4528-6981</orcidid><orcidid>https://orcid.org/0000-0001-8282-3323</orcidid><orcidid>https://orcid.org/0000-0002-2927-1731</orcidid><orcidid>https://orcid.org/0000-0002-9702-6770</orcidid><orcidid>https://orcid.org/0000-0002-5568-1531</orcidid><orcidid>https://orcid.org/0000-0002-6716-3344</orcidid></search><sort><creationdate>20230101</creationdate><title>Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes</title><author>Chen, Liangmiao ; Ye, Enling ; Sun, Mengli ; Lin, Hai ; Yu, Lechu ; Lin, Zhenzhen ; Peng, Mengmeng ; Lin, Dini ; Lu, Xuemian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-ea9fe2eda37604b82d1800907587b9dee0352c62068a8ebe531dc30c585f5ec23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Apgar score</topic><topic>Birth weight</topic><topic>Female</topic><topic>Fetal Distress</topic><topic>Fetuses</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - epidemiology</topic><topic>Pregnancy Outcome</topic><topic>Pregnancy Trimester, Third</topic><topic>Premature Birth</topic><topic>Premature rupture of membranes</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Rupture</topic><topic>Statistical analysis</topic><topic>Third trimester</topic><topic>Thyroid</topic><topic>Thyroid function</topic><topic>Thyroid gland</topic><topic>Thyroxine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Liangmiao</creatorcontrib><creatorcontrib>Ye, Enling</creatorcontrib><creatorcontrib>Sun, Mengli</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Yu, Lechu</creatorcontrib><creatorcontrib>Lin, Zhenzhen</creatorcontrib><creatorcontrib>Peng, Mengmeng</creatorcontrib><creatorcontrib>Lin, Dini</creatorcontrib><creatorcontrib>Lu, Xuemian</creatorcontrib><creatorcontrib>Shandong Provincial Hospital</creatorcontrib><creatorcontrib>Third Affiliated Hospital of Wenzhou Medical University</creatorcontrib><creatorcontrib>Department of Endocrinology</creatorcontrib><creatorcontrib>Shandong University</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Liangmiao</au><au>Ye, Enling</au><au>Sun, Mengli</au><au>Lin, Hai</au><au>Yu, Lechu</au><au>Lin, Zhenzhen</au><au>Peng, Mengmeng</au><au>Lin, Dini</au><au>Lu, Xuemian</au><aucorp>Shandong Provincial Hospital</aucorp><aucorp>Third Affiliated Hospital of Wenzhou Medical University</aucorp><aucorp>Department of Endocrinology</aucorp><aucorp>Shandong University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>70</volume><issue>6</issue><spage>611</spage><epage>618</epage><pages>611-618</pages><artnum>EJ22-0528</artnum><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012. Pregnant women were assigned to two groups, a hypothyroxinemia group (with maternal isolated hypothyroxinemia in the third trimester and normal thyroid function in the first and second trimesters) and a control group (with normal serum thyroid functions). The pregnancy outcomes, including preterm birth, fetal distress, birth weight, premature rupture of membranes, and Apgar score at one minute after the birth, were recorded and compared between the two groups. A total of 3,945 pregnant women (median age 26 year old) were included in the study, with 195 women in the hypothyroxinemia group and 3,750 women in the control group. Compared with the women in the control group, women in the hypothyroxinemia group had higher incidences of premature rupture of membranes and low Apgar score at one minute after the birth. The multivariate logistic regression analysis showed that the low third trimester serum thyroxine level was the independent risk factor for the premature rupture of membranes and low Apgar score. There were no statistically significant differences in preterm birth, macrosomia, and intrauterine fetal distress between two groups. Third trimester maternal isolated hypothyroxinemia was associated with adverse pregnancy outcomes. The maternal serum thyroxine level should be monitored during late pregnancy and necessary management should be applied to improve the pregnancy outcomes.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>37032065</pmid><doi>10.1507/endocrj.EJ22-0528</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-0882-4816</orcidid><orcidid>https://orcid.org/0000-0002-0560-4028</orcidid><orcidid>https://orcid.org/0000-0002-6687-5825</orcidid><orcidid>https://orcid.org/0000-0003-4528-6981</orcidid><orcidid>https://orcid.org/0000-0001-8282-3323</orcidid><orcidid>https://orcid.org/0000-0002-2927-1731</orcidid><orcidid>https://orcid.org/0000-0002-9702-6770</orcidid><orcidid>https://orcid.org/0000-0002-5568-1531</orcidid><orcidid>https://orcid.org/0000-0002-6716-3344</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2023, Vol.70(6), pp.611-618
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_2799172415
source J-STAGE Free; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Apgar score
Birth weight
Female
Fetal Distress
Fetuses
Humans
Infant, Newborn
Pregnancy
Pregnancy Complications - epidemiology
Pregnancy Outcome
Pregnancy Trimester, Third
Premature Birth
Premature rupture of membranes
Retrospective Studies
Risk factors
Rupture
Statistical analysis
Third trimester
Thyroid
Thyroid function
Thyroid gland
Thyroxine
title Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T09%3A19%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20third%20trimester%20maternal%20isolated%20hypothyroxinemia%20and%20adverse%20pregnancy%20outcomes&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=Chen,%20Liangmiao&rft.aucorp=Shandong%20Provincial%20Hospital&rft.date=2023-01-01&rft.volume=70&rft.issue=6&rft.spage=611&rft.epage=618&rft.pages=611-618&rft.artnum=EJ22-0528&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.EJ22-0528&rft_dat=%3Cproquest_cross%3E2799172415%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2850467109&rft_id=info:pmid/37032065&rfr_iscdi=true